source
- Flagship Pioneering merges three biotech startups to launch AI-driven drugmaker EtceleraFlagship Pioneering announced the creation of Etcelera Therapeutics by merging three of its portfolio companies - Etiome, Cellarity and Empress Therapeutics. The new venture will combine artificia…
- BMS drops $80 million neurodegeneration program after phase-1 resultsBMS announced it will not move forward with a neurodegeneration drug it licensed from Prothena, ending a program it invested $80 million in. The drug, known as BMS-986495 (formerly PRX019), comple…